Back
Sequential and Dual Inhibition of Pleiotropic Targets in Cancer—A Novel Strategy to Sensitize Tumor Cells to Targeted Therapies and Overcome Resistance
M. Nezami
J. Cancer Ther. Vol.10 No.2, February 21, 2019  DOI: 10.4236/jct.2019.102013
       (PDF  2513K)     HTML      XML
Evidence Based Medicine, in Precision Oncology
M. Nezami, Steve Hager
J. Cancer Ther. Vol.9 No.9, September 11, 2018  DOI: 10.4236/jct.2018.99057
       (PDF  2657K)     HTML      XML
Proof of Concept in a Case Study of Glioblastoma Multiforme Successfully Treated with IV Quercetin in Combination with Leading Edge Gamma Knife and Standard Treatments
M. A. Nezami, Christopher Duma
J. Cancer Ther. Vol.9 No.6, June 29, 2018  DOI: 10.4236/jct.2018.96043
       (PDF  948K)     HTML      XML
Role of Anti Angiogenic Therapy in Prevention of Recurrence in Hormonal Positive Breast Cancer: A Secondary Prevention Strategy and Method of Therapy
M. A. Nezami, Jessica Garner
J. Cancer Ther. Vol.8 No.6, June 20, 2017  DOI: 10.4236/jct.2017.86046
       (PDF  2097K)     HTML      XML
Biological Modulation of Parp Inhibition in Triple Negative Breast Cancer, a Combinational Approach Implementing Multitargeted Epigenetic Therapy (Mtet) with Parp Inhibition, in Advanced Breast Cancer: A Case Study
M. Nezami, Steve Hager, Julie Taguchi
J. Cancer Ther. Vol.9 No.9, September 11, 2018  DOI: 10.4236/jct.2018.99060
       (PDF  2152K)     HTML      XML
 
 
Top